Clinical Research Directory
Browse clinical research sites, groups, and studies.
Using Signos mHealth Platform in Adults for Weight Management
Sponsor: Signos Inc
Summary
Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral changes efforts, leading to improved adherence and results from diet and exercise changes in individuals with obesity. Mobile health (mHealth) platforms provide satisfactory, easy-to-use tools that help participants in the pursuit of weight change goals. The investigators hypothesize that the use of CGM data and targeted coaching and nutrition education will assist with weight optimization goals in the general (non-diabetic) population using the Signos mHealth platform, with associated health benefits.
Official title: A Randomized Controlled Trial Evaluating the Safety and Effectiveness of the Intelligently-Driven Signos System for Personalized Weight Management in Overweight and Obese Adults
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
380
Start Date
2024-01-02
Completion Date
2026-04-30
Last Updated
2024-10-08
Healthy Volunteers
Yes
Interventions
Signos System
The intervention involves the use of the Signos System, a combination of a proprietary software application with a continuous glucose monitor (CGM), to manage weight in overweight and obese adults.
Standard Lifestyle Education
In the "Standard Lifestyle Education" arm, participants receive conventional advice on diet and exercise, focusing on general healthy lifestyle habits to manage weight.
Locations (5)
Helios Clinical Research (Phoenix)
Phoenix, Arizona, United States
Diablo Clinical Research
Walnut Creek, California, United States
Segal Trials
North Miami, Florida, United States
Helios Clinical Research
Houston, Texas, United States
Seattle Clinical Research
Seattle, Washington, United States